Skip to search.
 TSX Down 0.67% TSX Ventures Up 0.03%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
2.76 Down 0.03(1.08%) Sep 23, 4:00PM EDT
|After Hours : 2.82 Up 0.06 (2.17%) Sep 23, 7:13PM EDT
Prev Close:2.79
Open:2.80
Bid:2.35 x 200
Ask:2.82 x 900
1y Target Est:5.00
Beta:2.2984
Earnings Date:Nov 4 - Nov 8 (Est.)
Day's Range:2.72 - 2.89
52wk Range:1.19 - 4.42
Volume:1,090,631
Avg Vol (3m):590,130
Market Cap:335.01M
P/E (ttm):N/A
EPS (ttm):-0.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IDRADown 1.08%335.01M
PFEUp 0.32%207.81B
DVAXDown 1.81%439.25M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):420.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.45
Quarterly EPS Est (Sep-16) :-0.11
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback